Chronic Renal Failure

Approval Given for Human Clinical Testing of Adsorbent Polymer Technology

Published in Blood Weekly, February 17th, 2000

RenalTech International, New York, announced that it has received approval from the Italian Ministry of Health to conduct human clinical testing of its adsorbent polymer technology for blood detoxification.

The study will investigate the use of the RenalTech BetaSorb device as an accessory to hemodialysis in patients with chronic kidney failure. RenalTech has selected San Bortolo Hospital in Vicenza, Italy, as the study site. San Bortolo is one of Europe's premiere dialysis research facilities, and has been instrumental in the testing of new devices to improve the therapy of chronic renal failure patients.

"Our technology addresses a looming health...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-02-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry